Henry Schein PE Ratio 2006-2018 | HSIC

Current and historical price to earnings ratio for Henry Schein (HSIC) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Henry Schein as of August 14, 2018 is 20.32.
Henry Schein Annual PE Ratio
Henry Schein Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $11.915B $12.462B
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.417B 23.78
Align Technology (ALGN) United States $29.098B 77.58
McKesson (MCK) United States $25.177B 9.64
Laboratory Of America Holdings (LH) United States $18.319B 16.85
AmerisourceBergen (ABC) United States $17.971B 13.06
Cardinal Health (CAH) United States $15.242B 10.22
Cooper (COO) United States $12.433B 23.14
DENTSPLY SIRONA (XRAY) United States $8.798B 15.40
West Pharmaceutical Services (WST) United States $8.466B 43.78
Merit Medical Systems (MMSI) United States $3.008B 39.53
Patterson (PDCO) United States $2.177B 13.63
CONMED (CNMD) United States $2.159B 36.58
STAAR Surgical (STAA) United States $1.742B 233.24
Atrion (ATRI) United States $1.193B 35.37
Invacare (IVC) United States $0.550B 0.00
Antares Pharma (ATRS) United States $0.504B 0.00
Endologix (ELGX) United States $0.232B 0.00
Lifevantage (LFVN) United States $0.139B 28.82
Aceto (ACET) United States $0.098B 3.97
Biolase (BIOL) United States $0.030B 0.00
Pro-Dex (PDEX) United States $0.029B 12.61
Milestone Scientific (MLSS) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.025B 0.00